Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Spectrum Vision Partners Expands its Service Footprint into Western New York with OCLI Vision’s Simultaneous Acquisition of Three Leading Ophthalmology Practices


OCLI Vision is making big headway into the Western New York area with the acquisition of three practices; Buffalo Niagara Retina Associates, Ophthalmology Associates of Western New York, and Retina Consultants of Western New York. This triple acquisition showcases OCLI Vision’s commitment to expanding superior eye care services and support for eye care professionals in the Northeast.

OCLI Vision, a multi-practice ophthalmology group with locations in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia, is expanding access to advanced eye care services throughout the region and supporting eye care specialists through innovative programs. OCLI Vision’s growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmology groups and ambulatory eye surgery centers in the Northeast.

The practices joining OCLI Vision have experienced teams and high-profile accolades to their names. Buffalo Niagara Retina Associates has been providing specialized eye care services focusing on diseases of the retina and vitreous to the western New York community since 1992. The practice consists of three retinal experts, each specializing in vitreo-retinal care.

“It’s an exciting time for our practice as we join the OCLI Vision team,” stated Dr. Martin A. Boscarino, MD. “We’re looking forward to connecting with the best eye care professionals in the industry and having access to an unprecedented professional network to help us expand the services we can provide to our valued patients.”

Ophthalmology Associates of Western New York has been serving families in the area for over 50 years. Ophthalmology Associates of Western New York’s team of five doctors provide comprehensive eye care services, including laser-assisted cataract surgery, treatment and surgery for glaucoma, and care for a wide-variety of complex eye disorders.

“OCLI Vision is the gold standard for multi-practice ophthalmology groups in the United States, and our team is thrilled to be joining this top-tier group of eye care professionals,” noted Dr. Charles Niles, MD. “By joining OCLI Vision, we’re getting access to a network of some of the most recognized professionals in the industry, state of the art practice management services, and much more. It’s a great opportunity for us to better care for our current patients, as well as, grow in the Western New York area, all while maintaining our commitment to the highest level of quality care.”

Retina Consultants of Western New York has been caring for patients for over 40 years, providing the latest in retinal condition treatment. With three locations and four experienced specialists, Retina Consultants brings experience and a strong presence in the Buffalo, NY community to the OCLI Vision team.

“We’re thrilled to be joining OCLI Vision,” noted Dr. Paul J. Lee, MD. “It’s been our ambition to further expand the care we can provide to the Western New York community. With OCLI Vision and its expansive network of specialized providers and clinics, we can reach more patients and continue applying the most advanced techniques and technology to the treatments we provide.”

HPC Puckett Advisory Company acted as the financial advisor for the Western New York practices.

For more information about OCLI Vision and Spectrum Vision Partners, please contact:

Tom Burke

Chief Executive Officer

tburke@spectrumvisionpartners.com

Greg Wappett

Chief Development Officer

gwappett@spectrumvisionpartners.com

About OCLI Vision

Founded in 1997, OCLI Vision (http://www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania, and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.

About Spectrum Vision Partners

Spectrum Vision Partners (SVP) (http://www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With over 1,400 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 50 clinic locations, five state-licensed ambulatory surgery centers, and over 140 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.

About Blue Sea Capital

Blue Sea Capital (http://www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies with EBITDA of up to $30 million. The firm has over $1.3 billion in committed capital and invests across three industry verticals: aerospace & defense, healthcare and industrial growth. Blue Sea Capital’s strategy is to partner with talented leaders and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.

Helix Professional Pain Relief Creams Announces Partnership with Pain Management Professional Dr. Joseph D. Salamone


pain cream

Helix Professional Pain Cream

“Helix Professional Pain Cream is very well tolerated by many patients, young and old, including a few of our 90-year-olds and even a centenarian!” – Dr. Joseph D. Salamone

Parker Laboratories, Inc., manufacturer and developer of Helix™ Professional Pain Relief Cream, announces a partnership with Dr. Joseph D. Salamone. Dr. Salamone is an expertly trained chiropractor and pain management professional with more than 30 years of experience helping patients find solutions to their chronic pain. Dr. Salamone will inform the future development of the Helix Professional Pain Relief product line and how the line is marketed to professionals including chiropractors, physical therapists, sports medicine practitioners, osteopaths, and massage therapists.

Dr. Salamone integrates several products from the Helix Professional Pain Relief line into his practice daily, stating, “With decades of experience as a chiropractor, I can say, without reservation, that Parker’s Helix Pain Relief creams provide effective relief. As the opioid and fentanyl epidemic in our country continues to be one of the biggest growing concerns, we have to address pain in multiple stages. Helix products, being nonaddictive, are used daily in our practice. This treatment, in conjunction with effective chiropractic care and therapy, helps decrease spasm, pain and swelling along the affected musculoskeletal areas. Helix Professional Pain Cream is very well tolerated by many patients, young and old, including a few of our 90-year-olds and even a centenarian!”

Helix Professional Pain Relief Cream is manufactured in America and exclusively sold to consumers through chiropractors, physical therapists, fitness professionals, and other pain care practitioners. Product formulations have been rigorously developed by Parker Laboratories and thoroughly tested to ensure safety, effectiveness, and consistency. The product line includes Helix Pain Relieving Cream, Tri-Active Therapy Cream, CBD Therapy Cream and CBD Clinical Cream. Professionals offering pain management solutions can visit http://www.helix4pain.com to request a product sampling.

About Parker Laboratories:

Parker Laboratories is a leading global medical products company that develops, manufactures, and markets pain relief creams, ultrasound and electromedical contact media and accessories, as well as leading lines of cleaners and disinfectants. A worldwide leader in ultrasound medical products for more than 65 years, Parker Laboratories is registered with the U.S. Food and Drug Administration as a manufacturer of medical devices and all its products are produced under Good Manufacturing Practices (GMP) directives. For more information, visit parkerlabs.com and helix4pain.com.

Share article on social media or email:

MCI USA Helps Launch Professional Society in Cutting-edge Science and Research


News Image

Opportunities to launch new organizations in high growth fields are directly aligned with our overall USA and global strategy, and we are honored to work with brilliant leaders creating the future of medicine.

MCI USA’s Association Solutions division is pleased to welcome the Society for RNA Therapeutics as a new full-service association management client. The mission of the newly formed nonprofit scientific society is to promote research, education, and developments in RNA therapeutics to improve global health. RNA therapeutics have the potential to revolutionize numerous potential medical applications, including treatment of genetic diseases, cancer treatment, vaccines, regenerative medicine, and rare diseases.

“MCI USA immediately saw the value and importance of helping to create a new organization to serve and support this incredibly dynamic area of science, medicine, and research. Opportunities to launch new organizations in high growth fields are directly aligned with our overall USA and global strategy, and we are honored to work with brilliant leaders creating the future of medicine,” said Erin Fuller, Chief Strategy Officer, MCI USA. “The MCI team is proud of our partnership with the inaugural board of directors to launch the Society for RNA Therapeutics, during this exciting time of establishing a new, global organization that will help treat genetic diseases and cancer as well as develop vaccines.”

The Society for RNA Therapeutics is a global network with goals that impact all aspects of RNA therapeutics:


  • Support translational research and development of RNA therapeutics
  • Develop standards for RNA manufacturing and guidelines for clinical trials
  • Facilitate public-private-regulatory partnerships and to advocate for accessible RNA therapeutics for all patients
  • Provide public and professional education and develop training guidelines
  • Advocate for patients with diseases amenable to RNA therapies
  • Develop clinical best practices in RNA therapeutics
  • Support early career and professional development
  • Advocate accessibility to RNA therapeutics for low and middle income countries for the enhancement of global health

“RNA therapeutics are changing the way medicine is developed and delivered,” said John P. Cooke, M.D., Ph.D., Founder and President of the Society for RNA Therapeutics. “The Society for RNA Therapeutics is led by an international group of scientists and physicians and is dedicated to serving scientists, clinicians, patient groups, policymakers and the broader public. Together, the Society will promote research, education and share key advances in this rapidly emerging field of medicine.”

For nearly 30 years, MCI USA’s Association Solutions division has helped advance the goals of its mission-driven nonprofit clients. With more than 150 Association Solutions employees in its Chicago and Washington, DC, offices, MCI USA provides results-oriented experience and expertise in full-service nonprofit management, strategic planning, community building, creative services, accounting practices, technology solutions, event conceptualization, and more.

Read more about the Society for RNA Therapeutics on the newly released website, http://www.srnat.org.

# # #

ABOUT MCI

MCI is a global engagement and marketing agency. We design human-centric solutions that unleash the power of people to deliver innovation and growth for our clients. Our offering includes live & virtual events, strategic & digital communications, consulting & community solutions. We help brands, companies, associations and not-for-profits solve their challenges, bringing their people together to shape their tomorrow. MCI is an independently owned company headquartered in Geneva, Switzerland, with a global presence in 60 offices across 31 countries. http://www.wearemci.com

MCI’s US headquarters is in the Washington, DC area with offices in New York, Baltimore, Dallas, and Chicago. http://www.wearemci.com/en-us

Share article on social media or email:

Illinois-Based Elderwerks Presents Live and Virtual Option Workshop For Caregivers Helping Loved Ones with Dementia; Nonprofit offers Dementia Academy training programs


In addition to monthly webinars and in-person events, the Illinois-based nonprofit Elderwerks offers specific training programs for professionals through its Dementia Academy.

“A majority of our calls are regarding changes in behavior, memory loss, next steps, and those in crisis due to a dementia diagnosis. We want to help people plan for these situations, understand how to engage, and how to cope through the entire process.”

As we age, we tend to forget certain things such as a house key or, perhaps, a phone number. We become more concerned as an older loved one does things that seem out of the ordinary such as having difficulty verbally communicating or losing interest in daily activities, or having an unusual emotional reaction to something mundane.

These could be signs of what is known as dementia. According to the National Institute on Aging, dementia “is the loss of cognitive functioning—thinking, remembering, and reasoning—to such an extent that it interferes with a person’s daily life and activities. Some people with dementia cannot control their emotions, and their personalities may change.” A recent study by Columbia University found that “almost 10% of U.S. adults ages 65 and older have dementia, while another 22% have mild cognitive impairment.”

Elderwerks, a Palatine, Illinois nonprofit offering senior living coordination, advocacy, and education is offering the public and professionals dementia training. From 1:30 to 2:30 p.m., Thursday, May 11 Elderwerks is offering a live and virtual presentation, “Caregiver Burnout: Caring for a Person Living with Dementia,” by Elderwerks Dementia Reality Master Trainer and Registered Nurse Chris Petrik. The program will cover what causes the stress of caregiving for a person living with dementia, how to identify the signs of strain, and how this situation affects both people from mental and physical standpoints.

“Dementia is a devastating disease that no one should go through alone, as a caregiver or as the person living with the disease,” said Elderwerks President Jennifer Prell. “Dementia education is important for anyone who encounters people with cognitive impairment. A majority of our calls are regarding changes in behavior, memory loss, next steps, and those in crisis due to a dementia diagnosis. We want to help people plan for these situations, understand how to engage, and how to cope through the entire process.”

In addition to monthly webinars and in-person events, Elderwerks offers specific training programs for professionals such as case managers, social workers, and memory support staff at all levels, the knowledge and tools they need through its Dementia Academy. Participants learn about memory loss, effective communication skills, and problem-solving remedies for people who exhibit challenging behavior.

“There has been a very positive response to these programs,” Prell said. “We receive many calls asking when the next dementia class is. They’re typically well attended, and many talk about how they learned a new perspective or new information from the classes.”

Within the Academy is a special program called Dementia Reality®, a collaboration between Elderwerks and CJE Senior Life, a Chicago nonprofit that also helps the needs of older adults. This program combines skills training with real-life obstacles in a virtual world. Master Trainers help participants gain skills training with real-life obstacles in a virtual world. There are classroom group discussions and follow-up periods.

“This program truly gives participants a first-hand experience in how they can help to improve the quality of care for a person living with dementia,” Prell said. “Those who enroll in the program can earn one and one-half hours of continuing education credits per module, 5 modules available. The Dementia Reality training teaches personhood, empathy, safety and understanding, and managing behaviors. Some benefits for clients and residents include better communication, improved behavioral outcomes, and decreased use of psychotropic medications.”

For more information, visit Elderwerks at https://www.elderwerks.org/.

About Elderwerks:

Based in Palatine, Elderwerks, a not-for-profit 501(c)3 organization, has helped thousands of older adults and seniors age well. Elderwerks offers complimentary information, referrals, and guidance for all types of senior living, home care, support services, and benefits based on your or your loved one’s needs. Acting as “senior guidance advisors,” we help find the right solutions for you or your loved one. Whether it’s assisted living, memory care, a referral for an elder law attorney, veterans benefit specialist, or transition to any other type of senior care, Elderwerks simplifies the process of navigating senior living options and supportive services. We can offer you support in a very short period. Don’t let the future overwhelm you, call Elderwerks first: 855-462-0100. For more information, visit Elderwerks’ website. ###

Share article on social media or email:

Brenda Doles, Principal of HCRS, To Attend WPO Conference in Las Vegas


News Image

It doesn’t matter what business you run. In this day and age, you can’t operate without data, and you can’t do well without strong data management.

Brenda Doles, principal of HCRS, is excited to attend the Women Presidents Organization’s Entrepreneurial Excellence Forum coming up May 10 – 12 in Las Vegas, Nevada. As noted on their website, this WPO event serves as “the premier gathering of women entrepreneurs who lead multi-million-dollar businesses,” with a focus on how to “build relationships, foster connections, and learn innovative ways to grow and thrive as individuals and leaders.”

As a member for 11 years, Doles is looking forward to the forum. “It’s always a source of inspiration meeting with fellow members and newcomers,” she notes. “Some of the most powerful stories … listening to Viola Davis tell her story, and how she managed to overcome extreme poverty and abuse. Despite these challenges, she never allowed anyone to dim her light, and from my perspective, she is a beacon of light.”

When we ask what Doles expects to see this year, she says, “building new relationships, learning innovative ways to grow and thrive as a leader, and exploring what’s shaping tomorrow’s markets.”

Doles adds that she also wouldn’t be surprised if the subjects of cybersecurity and data management both come up during plenty of conversations — and not simply because these are areas where her company excels. “It doesn’t matter what business you run,” Doles says. “In this day and age, you can’t operate without data, and you can’t do well without strong data management. The growing number of digital threats, coupled with increased enforcement for government contractors when it comes to CMMC [the Cybersecurity Maturity Model Certification], means that everyone needs to be concerned about how they record, organize, share, and protect their mission-critical information.”

Those who are interested in attending the WPO’s Entrepreneurial Excellence Forum can sign up on their website’s event page.

About WPO

The Women Presidents Organization has long served as a noncompetitive environment for female business professionals from around the world to meet and discuss many of the shared experiences and concerns within their leadership roles. The goal for every meeting is to offer understanding, support, and counsel. With over 2,000 members and 137 chapters in 10 countries, the WPO continues to foster inspiration, growth, and success.Click here to learn more about the organization and how to become a member.

About HCRS

Healthcare Resolution Services is a data management provider that leads teams of health information management (HIM) and medical professionals for organizations that require stronger analytics and compliance. They have over 25 years of expertise from partnering with contractors at the state, local, and federal levels of government. As a Registered Provider Organization (RPO), HCRS can also assist government contractors with qualifying for NIST SP 800-171 and the Cybersecurity Maturity Model Certification.

Click here to learn more about their services.

Share article on social media or email:

Orthofix STIM onTrack Recognized for Patient Engagement Innovation in 2023 MedTech Breakthrough Awards Program


News Image

“This award belongs to our dedicated team of employees who always put the patient first – we are grateful to them, and we are very pleased to accept this award from MedTech Breakthrough.” – Kevin Kenny, President of Orthofix Global Spine

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Orthofix, a global medical device company with a spine and orthopedics focus, has been selected as winner of the “Best Patient Engagement Mobile App” award in the 7th annual MedTech Breakthrough Awards program. The award recognizes the breakthrough innovation of the Orthofix STIM onTrack™ mobile app.

Developed to work with the latest generation CervicalStim™, SpinalStim™, and PhysioStim™ bone growth therapy devices, the STIM onTrack mobile app is designed to help patients adhere to their prescriptions and improve their clinical outcomes. For use with smartphones and other mobile devices, the app features include daily treatment reminders and device usage calendars to help patients stay on schedule with their therapy. Additionally, the app enables the sharing of treatment data and includes a patient reported outcome measure questionnaire (PROM). These responses are available to physicians in order to assist in understanding current treatment progress and overall recovery status for their patients.

“We are very proud of the STIM onTrack app and the work that went into developing this tool to assist patients in their recovery efforts,” said Kevin Kenny, President of Orthofix Global Spine. “This award belongs to our dedicated team of employees who always put the patient first – we are grateful to them, and we are very pleased to accept this award from MedTech Breakthrough.”

The STIM onTrack mobile app also provides links to educational patient resources and connects patients with a Patient Care team to help ensure patients understand their treatment regimens. Orthofix was the first to bring to market a patient mobile app for bone growth stimulation devices.

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“Research has shown that patients who take a more active role in their recovery and follow-up care have better overall outcomes. Digitizing care on a mobile app takes a familiar device – our phones – and provides a beneficial pathway for patients to adhere to treatment. Medical technology advancements can and should be designed to improve patient outcomes,” said James Johnson, managing director, MedTech Breakthrough. “STIM onTrack allows patients to actively engage in their own treatment plan, and the addition of the PROM questionnaire enables their providers to gain even more insight on how a patient is responding in real time, not just when they come in for a follow up. We extend our sincere congratulations to the entire Orthofix team for taking home a well-deserved 2023 MedTech Breakthrough Award.”

####

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical and health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience and Engagement, Health and Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information, visit MedTechBreakthrough.com.

About Orthofix

The newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.

The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil. For more information, please visit Orthofix.com.

Share article on social media or email:

Survey on Value of Flight Nursing Certification Featured in New Air Medical Journal Research Article


News Image

Today, over 5,700 RNs worldwide hold the Certified Flight Registered Nurse (CFRN) credential offered by the Board of Certification for Emergency Nursing.

“Flight nurses must safely provide appropriate, timely, and evidence-based care for patients of all ages in a highly autonomous, dynamic environment.”

According to a survey of nearly 1,000 registered nurses caring for critically ill or injured patients in the uniquely demanding, complex and high-stakes flight environment, flight nurses earn the Certified Flight Registered Nurse (CFRN) nursing specialty certification “to validate their clinical and patient care excellence, prepare themselves for the flight transport environment, for a competitive hiring advantage, and to lead by example.”

The 2022 Certified Flight Registered Nurse Pulse Survey, whose findings appear in a new, peer-reviewed Air Medical Journal original research article, is the first value of certification study of the CFRN flight nursing specialty credential. The CFRN was introduced by the Board of Certification for Emergency Nursing (BCEN) in July 1993. Today, there are over 5,700 CFRNs worldwide.

To earn the complex and multifaceted CFRN credential, nurses must pass a rigorous exam whose content spans clinical knowledge and professional issues specific to air medical transports, as well as safety, survival, disaster preparedness, scene operations management, communications, and equipment and aircraft knowledge.

“As the air medical transport community prepares to mark a milestone in our commitment to excellence, safety, and advancing patient care with the upcoming 30-year anniversary of flight nursing specialty certification, Air Medical Journal is pleased to present this important research,” said Air Medical Journal co-editor Eric R. Swanson, MD, FACEP, University of Utah School of Medicine, Division of Emergency Medicine, Salt Lake City, Utah.

According to the CFRN-certified nurses who responded to the BCEN survey:

  • The top perceived benefits of being a CFRN are a sense of accomplishment and pride (91%), flight physiology knowledge (85%), flight nursing clinical knowledge (83%), and confidence as a flight nurse (81%).
  • Since 2012, the annual number of initial CFRN certifications has increased an average of 22%, contributing to a fourfold increase in annual initial CFRN certifications from 2012-2022.
  • 35% have over 10 years of flight nursing experience.
  • 43% are employed by a stand-alone transport program, and another 25% work for a university/academic hospital or university/academic trauma program.
  • 70% of their time is spent in rotor-wing aircraft and 21% in fixed-wing aircraft.
  • The majority of their patients (49%) are adults aged 18-65, followed by adults over 65 years old (35%), with smaller percentages of pediatric and neonatal patients.

“Flight nurses must safely provide appropriate, timely, and evidence-based care for patients of all ages in a highly autonomous, dynamic environment,” said article co-author and BCEN CEO Janie Schumaker, MBA, BSN, RN, CEN, CENP, CPHQ, FABC. “CFRN certification independently validates their advanced clinical and operational knowledge across all aspects of flight nursing, and the renewal process provides an invaluable framework to ensure their flight nursing expertise remains current and relevant over time.”

RNs responding to BCEN’s CFRN Pulse Survey in October and November 2022 evaluated the CFRN across 13 value of certification categories and shared nursing career and practice environment demographics, transport mode and patient population types, benefits of CFRN certification during the COVID-19 pandemic, and reasons for earning the CFRN.

Findings from BCEN’s companion survey on certification in the ground transport setting, The 2022 Certified Transport Registered Nurse Survey, appeared in the January/February 2023 issue of Air Medical Journal (available via free access).

“This CFRN certification study, in combination with the recent critical care ground transport companion study, provides important insight into what flight and critical care transport nurses perceive as benefits of advanced certification, and how holding a mode-specific transport credential validates their dedication to safety, professionalism, and patient care excellence in the out-of-hospital environment,” said article co-author Jacqueline C. Stocking, PhD, MBA, MSN, NEA-BC, CMTE, CEN, CFRN, FP-C, CCP-C, RN, NREMT-P, University of California Davis Medical Center, Sacramento, California. Stocking is a long-time editor of Air Medical Journal; her co-editor conducted the editorial process for this article.

About BCEN

Founded in 1980, the independent, not-for-profit Board of Certification for Emergency Nursing (BCEN®) offers robust nursing specialty certification programs fostering empowered nurses across the emergency spectrum who contribute noticeably to patient care, safety and outcomes. Over 59,000 BCEN credentials are held by RNs and advanced practice RNs who specialize in emergency, flight, critical care ground transport, pediatric emergency and trauma nursing. BCEN offers the Certified Emergency Nurse (CEN®), Certified Flight Registered Nurse (CFRN®), Certified Pediatric Emergency Nurse (CPEN®), Certified Transport Registered Nurse (CTRN®) and Trauma Certified Registered Nurse (TCRN®) certification programs.

About Air Medical Journal

Air Medical Journal (AMJ) is the official journal of the five leading air medical transport associations in the United States: the Association of Air Medical Services, Air Medical Physician Association, Air & Surface Transport Nurses Association, National EMS Pilots Association, and International College of Advanced Practice Paramedics. Published by Elsevier, AMJ is the premier provider of information for the medical transport industry, addressing the unique concerns of medical transport physicians, nurses, pilots, paramedics, emergency medical technicians, communication specialists, and program administrators.

# # #

Reducing Caregiver Burden in Alzheimer’s Disease Clinical Trials to Boost Patient Recruitment, Upcoming Webinar Hosted by Xtalks


During a clinical trial the ‘caregiver’ becomes the ‘study partner’ and is essential for the success of clinical research.

Caregivers play a critical role in clinical research since they are the closest and most constant observer of the individual living with dementia. During a clinical trial the ‘caregiver’ becomes the ‘study partner’ and is essential for the success of clinical research. Study retention and adherence to study protocol is a crucial consideration in Alzheimer’s disease trials. Caregivers play a vital role in the landscape of dementia clinical trials by supporting protocol tasks and ensuring participants attend all required visits.

Join this webinar to learn why it is critical that early program design include strategies to address the caregiver needs, thereby reducing burden and boosting patient recruitment and retention.

Join experts from PPD, part of Thermo Fisher Scientific, Dr. Sabine Krofczik-Wilhelm, PhD, Executive Director, Neuroscience; Dr. Bruce Hoffen, MD, Principal Investigator, Orlando Clinic; and Eve Kamau, MSc, RN, Sr. Director Home Trial Services, for the live webinar on Wednesday, May 24, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Reducing Caregiver Burden in Alzheimer’s Disease Clinical Trials to Boost Patient Recruitment.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Bringing Clinical Trial Access to Underserved Populations in a Community Setting, Upcoming Webinar Hosted by Xtalks


Innovative and scalable solutions that are industry compliant are needed to make equity a reality, thus bringing clinical trial access to underserved populations.

Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent of the US population has participated in a trial, of which only six percent represent Black and Latinx populations, even though those groups make up nearly 30 percent of the US population. Innovative and scalable solutions that are industry compliant are needed to make equity a reality, thus bringing clinical trial access to underserved populations.

This webinar will provide an opportunity to discover a model that provides clinical trial access to previously under-represented and underserved populations while removing barriers and unlocking doors to innovation. Imagine a trial that adjusts to patients’ schedules, travel capabilities and daily life obligations.

Join featured speakers from PPD and EmVenio Research as they lead a discussion of how localization — learning and adapting to a community’s local language, culture and traditions — has and can increase trial awareness, and clinical trial access to patients everywhere, making equity a reality, leading to an improved patient experience.

Register now to join the discussion on increasing study enrollment, enabling greater diversity and thinking differently about engaging underserved populations.

Join John Manns, Senior Director, Consultancy, Innovation & Strategy, Digital and Decentralized Solutions, PPD; Thad Wolfram, President, EmVenio Research; and Niambi Blodgett, Director, Global Patient Engagement, EmVenio Research, for the live webinar on Tuesday, May 23, 2023, at 12pm EDT (9am PDT).

For more information, or to register for this event, visit Bringing Clinical Trial Access to Underserved Populations in a Community Setting.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Scientist.com Reaches 10 Million Human Sample Milestone in Drug Research


News Image

“Surpassing 10 million plus samples sourced through the platform is a remarkable achievement that further validates the level of trust our clients and suppliers have in us as well as the due diligence we undertake,” stated Matt McLoughlin, Sr. VP of Compliance & Categories at Scientist.com.

In a testament to its growing impact on preclinical drug research, Scientist.com, the leading online R&D marketplace for the biopharmaceutical industry, announced today that it has successfully sourced over 10 million human biological samples through its platform. Since 2007, Scientist.com has been dedicated to connecting biopharma researchers in need of human biosamples for their research studies with a global network of sample providers and biobanks.

“Surpassing 10 million plus samples sourced through the platform is a remarkable achievement that further validates the level of trust our clients and suppliers have in us as well as the due diligence we undertake,” stated Matt McLoughlin, Sr. VP of Compliance & Categories at Scientist.com. “Seeing how we have supported and impacted drug discovery and development across the industry strengthens our resolve of helping cure all diseases by 2050.”

Human biospecimens play an important role across the entire drug discovery research pipeline, serving as invaluable resources for target discovery, target validation, lead optimization, translational research and clinical development. To mitigate risks associated with sourcing human samples, Scientist.com introduced the award-winning compliance platform, COMPLi®, in 2015. COMPLi minimizes risks through a comprehensive, proprietary due diligence process conducted on all providers offering human biological samples and all users requesting samples for scientific research.

About Scientist.com

Scientist.com’s mission is to empower and connect scientists worldwide. The company’s state-of-the-art digital research platform combines custom-built, cloud-native technology with exceptional customer and scientific support, enabling scientists to conduct more innovative experiments in less time and at reduced costs. Scientist.com leverages its internally developed machine learning models to provide actionable insights that enhance operational efficiency and effective research management. The company connects the world’s leading pharmaceutical companies, biotechnology firms, and the US National Institutes of Health (NIH) to the world’s largest global network of scientific suppliers.

Visit Scientist.com to learn more.

Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

Share article on social media or email: